Billionaire Ken Fisher's Top Stock Picks

Find out which three stocks top Fisher's fund holdings and why.

Apr 22, 2014 at 4:04PM

Money managers must disclose their stock holdings every quarter, giving investors like you and me a peek into their portfolios. Based on his firm's first-quarter 13F SEC filing, here are multibillion-dollar fund manager Ken Fisher's top three stock holdings.

Fisher's favorites
The largest single stock holding in Fisher's fund is American Express (NYSE:AXP). Unlike its credit card-issuing peers, which generate the majority of their revenue by charging interest on loan balances that customers carry, American Express relies heavily on merchant fees and the annual fees it charges its cardholders. American Express can charge higher fees to merchants than competitors for two key reasons. First, American Express cardholders spend more on average than holders of other cards. Second, American Express offers merchants valuable marketing data on the spending behaviors of affluent consumers. American Express' global potential provides a compelling opportunity for growth. The company has successfully shifted its domestic focus to charge cards and co-branded cards, which attract customers who prefer to pay with plastic but don't want to accumulate debt. The company's revenue generation outside the U.S. will likely accelerate as its cards are accepted at more locations and spending growth in emerging countries outpaces U.S. spending growth. 

Health care conglomerate Johnson & Johnson (NYSE:JNJ) is Fisher's second-largest stock holding, making up 2.2% of his fund's portfolio. Mitigating the risk of possible decline in any single business segment, the maker of Tylenol, Band-Aids, and Neutrogena boasts leading positions in pharmaceuticals, medical devices and diagnostics, and consumer health. No more than 14% of revenue is derived from any single company division. J&J boasts an opportunity for growth from its extensive late-stage biopharmaceutical pipeline, which has led to many recent new drug launches. New products are in attractive therapeutic areas such as prostate cancer, hepatitis C, and diabetes. With major patent expirations largely behind J&J, the new specialty-focused products should help to accelerate growth and drive earnings even higher in future years. The drugmaker's pharmaceutical segment enjoyed 10.9% sales growth in 2013.

Drugmaker Pfizer (NYSE:PFE) is his fund's third-largest single stock holding. The pharmaceutical giant acquired many companies during the past few years. But recently, Pfizer has been divesting its noncore businesses. As Pfizer becomes a smaller company by unloading its nonpharmaceutical businesses, successful pipeline products should have a bigger impact on the company's growth and profitability. Like J&J, Pfizer boasts an opportunity for growth from its extensive late-stage biopharmaceutical pipeline. Pfizer currently has about 80 drugs in various stages of clinical development, with roughly one-third in late-stage development. Additionally, products for stroke prevention and rheumatoid arthritis have been approved in recent years. And promising drugs in development treatments for various forms of cancer. The maker of Viagra and Lipitor makes up more than 2% of Fisher's portfolio. 

Foolish takeaway
Fisher's confidence in these three stocks -- or the financial-services and health-care sectors in general -- may be your cue to consider similar positions in your own portfolio.

3 Stocks Poised to Be Multibaggers
The one sure way to get wealthy is to invest in a groundbreaking company that goes on to dominate a multibillion-dollar industry. Our analysts have found multibagger stocks time and again. And now they think they've done it again with three stock picks that they believe could generate the same type of phenomenal returns. They've revealed these picks in a new free report that you can download instantly by clicking here now.

Nicole Seghetti owns shares of Johnson & Johnson and Pfizer. Follow her on Twitter @NicoleSeghetti. The Motley Fool recommends American Express and Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers